/Investor DB

Clarus Ventures — 2015 Investments

2 investments dated 2015 · listed companies and verified rows first · show all

Catabasis PharmaceuticalsinMar 2015SEC filingmedium confidence

BiotechCambridge, US

Jill C. Milne(Executive Officer, Director)inIan Sanderson(Executive Officer)in

BoardRon Laufer(Director)Jean George(Director)Michael Ross(Director)

Board seatNicholas Galakatos· per SEC Form D · $20.4M raise · filed Mar 2015

Co-investorsLightstone Ventures

Venus Conceptvenusconcept.comin𝕏May 2015SEC filingmedium confidence

Venus develops non-invasive, energy-based medical aesthetic devices for body, face, skin, and hair treatments, integrating robotics, AI, and IoT technologies.

BiotechHardwareHealthtechMedical DevicesToronto, US

Domenic Serafino(Executive Officer, Director)inKirk Gunhus(Executive Officer)inRoss Portaro(Executive Officer)inAnna Georgiadis(Executive Officer)inMelissa Kang(Executive Officer)inMichael Mandarello(Executive Officer)in

Board seatEmmett CunninghamEmmett Cunningham, Jr.· per SEC Form D · $26M raise · filed Aug 2017

Co-investorsAPERTURE Venture PartnersEssex Woodlands Healthcare PartnersLongitude CapitalHealthQuest Capital

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.